Boesen Biotech ApS: Financial statements 2018
CVR: 39142635
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Boesen Biotech ApS (CVR 39142635) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -20,020 and a net result of DKK -535,708 compared with DKK 260,637 the year before. Equity in the 2018 report amounted to DKK -225,071.
- Gross Profit
- DKK -20,020
- Profit/Loss
- DKK -535,708
- Equity
- DKK -225,071
- Total Assets
- DKK 3,589,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -20 t. | -536 t. | -225 t. | - |
| 2017 | - | -19 t. | 261 t. | 311 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Boesen Biotech ApS has published its annual report for 2017. Gross profit came to DKK -18,750, and the net result was DKK 260,637.
As of January 15, 2018, T. BOESEN HOLDING ApS is registered as an owner of Boesen Biotech ApS with an ownership share of 66%.
About Boesen Biotech ApS
Boesen Biotech ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Thomas Boesen. The company is owned by T. BOESEN HOLDING ApS and Gudter ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -54,998 and a net result of DKK 2,039,886 compared with DKK 723,812 the year before. Equity in the 2025 report amounted to DKK 3,496,600.